EVIO (EVIO) Stock Price, News & Analysis

Company Overview

EVIO (OTCMKTS:EVIO) operates a network of analytical testing laboratories specializing in the cannabis and hemp industries. The company provides a comprehensive range of quality assurance and regulatory compliance services designed to support cultivators, processors and product manufacturers. Through its accredited facilities, EVIO performs testing for cannabinoids, terpenes, pesticides, heavy metals, residual solvents, mycotoxins and microbial contaminants, helping clients meet state and federal guidelines while ensuring product safety and consistency.

EVIO’s laboratories utilize advanced instrumentation, including high-performance liquid chromatography (HPLC), gas chromatography (GC) and mass spectrometry (MS), to deliver accurate and timely results. The company also offers formulation support, stability testing and advisory services, assisting customers in product development and optimization. By combining analytical expertise with regulatory knowledge, EVIO aims to streamline the testing process and drive industry best practices.

Founded in 2014 and headquartered in Sarasota, Florida, EVIO has expanded its footprint across multiple U.S. jurisdictions, operating facilities in key cannabis markets such as California, Oregon, Michigan, Maryland and Washington. The company’s growth has been fueled by strategic partnerships, acquisitions and facility build-outs, positioning EVIO as one of the largest multistate testing providers in the sector. Its network model allows the firm to offer consistent testing protocols and centralized reporting across diverse regulatory environments.

Leadership at EVIO includes founder and Chief Executive Officer Colton Gardner, who has overseen the company’s evolution from a single laboratory into a nationwide testing platform. Under his direction, EVIO continues to invest in state-of-the-art technologies and expand its service offerings, catering to licensed cannabis and hemp producers as well as research institutions and regulatory bodies. The company’s commitment to quality, accuracy and compliance underpins its role as a critical partner in the legal cannabis supply chain.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1.42 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EVIO Stock Analysis - Frequently Asked Questions

How do I buy shares of EVIO?

Shares of EVIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of EVIO own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EVIO investors own include Organigram Global (OGI), Unrivaled Brands (TRTC), Aurora Cannabis (ACB), Singlepoint (SING), Aethlon Medical (AEMD), 22nd Century Group (XXII) and Invictus MD Strategies (IVITF).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:EVIO
• CIK: 715788
• Web: www.eviolabs.com
• Phone: (888) 544-3846
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A